These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8654608)

  • 21. [Relationship between lymphatic metastasis in breast and cervix cancers and the level of CD44-H expression evaluated by an immunohistochemical method].
    Yahyaoui O; Guerbaoui M; Oudghiri M
    Gynecol Obstet Fertil; 2001 Jun; 29(6):422-6. PubMed ID: 11462957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of CD44 isoforms in human skin cancer.
    Simon JC; Heider KH; Dietrich A; Wuttig C; Schöpf E; Adolf GR; Ponta H; Herrlich P
    Eur J Cancer; 1996 Jul; 32A(8):1394-400. PubMed ID: 8869105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.
    Chen J; Zhou J; Lu J; Xiong H; Shi X; Gong L
    BMC Cancer; 2014 Jan; 14():15. PubMed ID: 24410905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin.
    Salmi M; Grön-Virta K; Sointu P; Grenman R; Kalimo H; Jalkanen S
    J Cell Biol; 1993 Jul; 122(2):431-42. PubMed ID: 8320265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and cynomolgus monkeys.
    Heider KH; Mulder JW; Ostermann E; Susani S; Patzelt E; Pals ST; Adolf GR
    Eur J Cancer; 1995 Dec; 31A(13-14):2385-91. PubMed ID: 8652273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of angiogenesis, laminin and CD44 expression in metastatic behavior of early-stage low-grade invasive breast carcinomas.
    Ozer E; Canda T; Kurtodlu B
    Cancer Lett; 1997 Dec; 121(2):119-23. PubMed ID: 9570348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
    Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
    Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unaltered strong immunohistochemical expression of CD44-v6 and -v5 isoforms during development and progression of oral squamous cell carcinomas.
    Piffkò J; Bànkfalvi A; Klauke K; Dreier R; Joos U; Böcker W; Schmid KW
    J Oral Pathol Med; 1996 Oct; 25(9):502-6. PubMed ID: 8959559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
    Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
    Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High ASMA
    Amornsupak K; Jamjuntra P; Warnnissorn M; O-Charoenrat P; Sa-Nguanraksa D; Thuwajit P; Eccles SA; Thuwajit C
    Clin Breast Cancer; 2017 Oct; 17(6):441-452.e2. PubMed ID: 28533055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma.
    Gotoda T; Matsumura Y; Kondo H; Ono H; Kanamoto A; Kato H; Watanabe H; Tachimori Y; Nakanishi Y; Kakizoe T
    Gut; 2000 Jan; 46(1):14-9. PubMed ID: 10601048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva.
    Tempfer C; Gitsch G; Haeusler G; Reinthaller A; Koelbl H; Kainz C
    Cancer; 1996 Jul; 78(2):273-7. PubMed ID: 8674003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of CD44 splice variants in human skin and epidermal tumours.
    Seiter S; Tilgen W; Herrmann K; Schadendorf D; Patzelt E; Möller P; Zöller M
    Virchows Arch; 1996 Jun; 428(3):141-9. PubMed ID: 8688968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD44 as a marker in human cancers.
    Sy MS; Mori H; Liu D
    Curr Opin Oncol; 1997 Jan; 9(1):108-12. PubMed ID: 9090502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CD44 splice variants during lymphocyte activation and tumor progression.
    Griffioen AW; Horst E; Heider KH; Wielenga VJ; Adolf GR; Herrlich P; Pals ST
    Cell Adhes Commun; 1994 Jul; 2(3):195-200. PubMed ID: 7530151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
    Chen Y; Song J; Jiang Y; Yu C; Ma Z
    Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD44 isoforms in prognosis of breast cancer.
    Kaufmann M; Heider KH; Sinn HP; von Minckwitz G; Ponta H; Herrlich P
    Lancet; 1995 Aug; 346(8973):502. PubMed ID: 7543643
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas.
    Satoh K; Shimosegawa T; Koizumi M; Toyota T
    Anticancer Res; 1997; 17(1A):215-9. PubMed ID: 9066654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of CD44 and isoforms v4, v5, v6, v7, v10--new prognostic parameters in ductal pancreatic carcinoma?].
    Böttger T; Maschek H; Gottwald W; Lobo M; Brenner W; Junginger T
    Chirurg; 1998 Oct; 69(10):1089-92. PubMed ID: 9833191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.